MyAverix Finance MyAverix Finance

KO

Samsung Biologics (SAMSUNG BIOLOGICS)

Samsung Biologics (SAMSUNG BIOLOGICS) is listed on KO. As of 2026-05-21, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-21

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for SAMSUNG BIOLOGICS

P/E ratio
18.00

Samsung Biologics (SAMSUNG BIOLOGICS) — FAQ

What is SAMSUNG BIOLOGICS's P/E ratio?

The price-to-earnings (P/E) ratio for Samsung Biologics (SAMSUNG BIOLOGICS) is 18.00 (data as of 2026-05-21).

Does Samsung Biologics pay a dividend?

Dividend yield is not available in the current snapshot for Samsung Biologics (SAMSUNG BIOLOGICS). Check the MyAverix Finance app for the latest dividend data.

What exchange is SAMSUNG BIOLOGICS listed on?

SAMSUNG BIOLOGICS is listed on KO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play